However, since MPNST are not homogeneous tumours and may harbour different genetic alterations that might influence the Akt/mTOR pathway further studies are needed to clarify the impact of Pten status for therapeutic strategies. The gene discussed is AKT1; the disease is malignant peripheral nerve sheath tumor.